Show results for
Refine by
Locations
- Europe
- Albania
- Andorra
- Austria
- Belarus
- Belgium
- Bosnia & Herzegovina
- Bulgaria
- Croatia
- Cyprus
- Czech Republic
- Denmark
- Estonia
- Faroe Islands
- Finland
- France
- Germany
- Greece
- Hungary
- Iceland
- Ireland
- Italy
- Kosovo
- Latvia
- Liechtenstein
- Lithuania
- Luxembourg
- Macedonia
- Malta
- Moldova
- Monaco
- Montenegro
- Netherlands
- Northern Ireland
- Norway
- Poland
- Portugal
- Romania
- San Marino
- Serbia
- Slovakia
- Slovenia
- Spain
- Sweden
- Switzerland
- Turkey
- Ukraine
- United Kingdom
- Vatican City
Prostate Specific Antigen Equipment Supplied In Europe
8 equipment items found
Manufactured by:Advanced Accelerator Applications SA based inRueil-Malmaison Cedex, FRANCE
LOCAMETZ, after radiolabeling with gallium-68, is a radioactive diagnostic agent indicated for positron emission tomography (PET) of prostate-specific membrane antigen (PSMA)-positive lesions in men with prostate cancer: with suspected metastasis who are candidates for initial definitive therapy, with suspected recurrence based ...
Manufactured by:Sekisui Diagnostics, LLC based inBurlington, MASSACHUSETTS (USA)
FastPack® IP Free PSA immunoassay is a chemiluminescent immunoassay for the in-vitro quantitative determination of free prostate-specific antigen (free PSA) in human serum. FastPack® IP Free PSA immunoassay is designed for use in conjunction with the FastPack® IP System for calculating the ratio of free/total PSA, expressed as a ...
Manufactured by:LAVA Therapeutics N.V. based inUtrecht, NETHERLANDS
LAVA-1207, a gamma-delta bsTCE targeting the prostate specific membrane antigen (PSMA), has also demonstrated preclinical proof-of-concept. We expect to initiate a Phase I/IIa trial in metastatic castration-resistant prostate cancer in the second half of ...
Manufactured by:in.vent Diagnostica GmbH based inBerlin, GERMANY
in.vent quality controls are used for internal and external quality control (e.g. for ring tests) and meet the highest standards of medical laboratories. Our control samples are based on real patient samples and are largely made from native human ...
Manufactured by:Blue Earth Diagnostics based inOxford, UNITED KINGDOM
The targeting molecule delivers a therapeutic dose of radiation to kill tumour cells. Blue Earth Diagnostics acquired exclusive, worldwide rights to radiohybrid Prostate Specific Membrane Antigen (rhPSMA) targeted technology in order to expand its oncology imaging and theranostics portfolio. The Company is investigating the use of rhPSMA (18F) as ...
Manufactured by:Exosome Diagnostics, Inc. based inWaltham, MASSACHUSETTS (USA)
The ExoDx Prostate is a simple, non-invasive urine test that can discriminate the risk of aggressive prostate cancer (defined as Gleason Score ≥7). This test is now available as an At-Home Collection Kit that can be initiated by an electronic order signed by the physician and sent directly to the patient’s home for ...
Manufactured by:Exosome Diagnostics, Inc. based inWaltham, MASSACHUSETTS (USA)
The only exosome-based test that provides unique, actionable intelligence to help you decide if biopsy is necessary; independent of PSA and other standard of care (SOC) features. Connect with a representative in your area for more information today. ...
Manufactured by:ITM Isotope Technologies Munich SE based inGarching / Munich, GERMANY
iQS-TS is a fully automated cassette-based Theranostics Synthesizer facilitating the routine preparation of radiolabeled ...